» Articles » PMID: 38878866

Consequences of Low Estimated Glomerular Filtration Rate Either Before or Early After Kidney Donation

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2024 Jun 15
PMID 38878866
Authors
Affiliations
Soon will be listed here.
Abstract

In the general population, decreases in glomerular filtration rate (GFR) are associated with subsequent development of chronic kidney disease (CKD), cardiovascular disease (CVD), and death. It is unknown if low estimated GFR (eGFR) before or early after kidney donation was also associated with these risks. One thousand six hundred ninety-nine living donors who had both predonation and early (4-10 weeks) postdonation eGFR were included. We studied the relationships between eGFR, age at donation, and the time to sustained eGFR<45 (CKD stage 3b) and <30 mL/min/1.73m (CKD stage 4), hypertension, diabetes mellitus (DM), CVD, and death. Median follow-up was 12 (interquartile range, 6-21) years. Twenty-year event rates were 5.8% eGFR<45 mL/min/1.73m; 1.2% eGFR<30 mL/min/1.73m; 29.0% hypertension; 7.8% DM; 8.0% CVD; and 5.2% death. The median time to eGFR<45 mL/min/1.73m (N = 79) was 17 years, and eGFR<30 mL/min/1.73m (N = 22) was 25 years. Both low predonation and early postdonation eGFR were associated with eGFR<45 mL/min/1.73m (P < .0001) and eGFR<30 mL/min/1.73m (P < .006); however, the primary driver of risk for all ages was low postdonation (rather than predonation) eGFR. Predonation and postdonation eGFR were not associated with hypertension, DM, CVD, or death. Low predonation and early postdonation eGFR are risk factors for developing eGFR<45 mL/min/1.73m (CKD stage 3b) and <30 mL/min/1.73m (CKD stage 4), but not CVD, hypertension, DM, or death.

Citing Articles

Evaluating Risk in Kidney Living Donors.

Ortiz F, Marson L, Thomas R, Kousios A, Rista E, Lefaucheur C Transpl Int. 2025; 38:14024.

PMID: 40078501 PMC: 11896807. DOI: 10.3389/ti.2025.14024.

References
1.
Locke J, Reed R, Massie A, Maclennan P, Sawinski D, Kumar V . Obesity and long-term mortality risk among living kidney donors. Surgery. 2019; 166(2):205-208. PMC: 6660998. DOI: 10.1016/j.surg.2019.03.016. View

2.
Bambha K, Kim N, Sturdevant M, Perkins J, Kling C, Bakthavatsalam R . Maximizing utility of nondirected living liver donor grafts using machine learning. Front Immunol. 2023; 14:1194338. PMC: 10344453. DOI: 10.3389/fimmu.2023.1194338. View

3.
Baralou V, Kalpourtzi N, Touloumi G . Individual risk prediction: Comparing random forests with Cox proportional-hazards model by a simulation study. Biom J. 2022; 65(6):e2100380. DOI: 10.1002/bimj.202100380. View

4.
Haugen A, Hallan S, Langberg N, Dahle D, Pihlstrom H, Birkeland K . Increased risk of ischaemic heart disease after kidney donation. Nephrol Dial Transplant. 2021; 37(5):928-936. PMC: 9035350. DOI: 10.1093/ndt/gfab054. View

5.
Dong J, Buradagunta C, Zhang T, Spellman S, Bolon Y, DeZern A . Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation. J Hematol Oncol. 2023; 16(1):21. PMC: 9999628. DOI: 10.1186/s13045-023-01418-4. View